Determination of flunixin and ketoprofen in milk by liquid chromatography-tandem mass spectrometry

被引:40
作者
Daeseleire, E
Mortier, L
De Ruyck, H
Geerts, N
机构
[1] Agr Res Ctr Ghent, CLO, Minist Flemish Community, Dept Anim Prod Qual & Transformat Technol,DVK, B-9090 Melle, Belgium
[2] Agr Res Ctr Ghent, CLO, Minist Flemish Community, Dept Anim Nutr & Husb,Sect Cattle & Pig Husb,DVV, B-9820 Merelbeke, Belgium
关键词
ketoprofen; flunixm; milk; mass spectrometry; residues;
D O I
10.1016/S0003-2670(03)00577-4
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A relatively fast, simple and very selective liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for the detection of flunixin, its 5-hydroxymetabolite and ketoprofen in raw milk has been developed and validated. After a simple extraction with acetonitrile and partial evaporation of the organic phase, the extract was filtered and directly injected into the LC-MS-MS system on a Symmetry C-18 column. The parent ions were selected for further fragmentation with argon. The method developed was partially validated according to Commission Decision 2002/657/EC [Commission Decision 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results]. The validation parameters were linearity, specificity, repeatability, recovery and decision limit (CCalpha). CCalpha varied from 0.5 mug kg(-1) for flunixin and 5-hydroxyflunixin to I mug kg(-1) for ketoprofen. Holstein-Friesian cows were given either Ketofen(R) or Finadyne(R) via an intravenous injection at the maximum dose as written in the instructions. Cows were milked twice a day and all samples were analysed by the method described. The highest concentrations found for ketoprofen, flunixin and 5-hydroxyflunixin were 2.5, 6.7 and 590 mug l(-1), respectively. The concentration of 5-hydroxyflunixin declined rapidly to concentrations below the MRL value of 40 mug l(-1). It can be concluded that the withdrawal time proposed by the pharmaceutical companies, 12 h after the last dosing, is acceptable for both compounds. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:25 / 34
页数:10
相关论文
共 27 条
[11]   SIMULTANEOUS DETERMINATION OF FLUNIXIN, PHENYLBUTAZONE, OXYPHENBUTAZONE AND GAMMA-HYDROXYPHENYLBUTAZONE IN EQUINE PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - WITH APPLICATION TO PHARMACOKINETICS [J].
HARDEE, GE ;
LAI, JW ;
MOORE, JN .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1982, 5 (10) :1991-2003
[12]   Comparison of packed column supercritical fluid chromatography-tandem mass spectrometry with liquid chromatography-tandem mass spectrometry for bioanalytical determination of (R)- and (S)-ketoprofen in human plasma following automated 96 well solid-phase extraction [J].
Hoke, SH ;
Pinkston, JD ;
Bailey, RE ;
Tanguay, SL ;
Eichhold, TH .
ANALYTICAL CHEMISTRY, 2000, 72 (17) :4235-4241
[13]   IDENTIFICATION OF A FLUNIXIN METABOLITE IN THE HORSE BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY [J].
JAUSSAUD, P ;
COURTOT, D ;
GUYOT, JL ;
PARIS, J .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 423 :123-130
[14]   Measurement of ketoprofen in horse urine using gas chromatography-mass spectrometry [J].
Kim, JY ;
Kim, SJ ;
Paeng, KJ ;
Chung, BC .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2001, 24 (05) :315-319
[15]  
KOPCHA M, 1992, J AM VET MED ASSOC, V201, P1868
[16]  
Leis HJ, 1996, J MASS SPECTROM, V31, P486
[17]   FLUNIXIN MEGLUMINE AND FLURBIPROFEN IN COWS WITH EXPERIMENTAL ESCHERICHIA-COLI MASTITIS [J].
LOHUIS, JACM ;
VANLEEUWEN, W ;
VERHEIJDEN, JHM ;
BRAND, A ;
VANMIERT, ASJPAM .
VETERINARY RECORD, 1989, 124 (12) :305-308
[18]   Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation [J].
Maurer, HH ;
Tauvel, FX ;
Kraemer, T .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2001, 25 (04) :237-244
[19]  
Morin DE, 1998, J AM VET MED ASSOC, V213, P676
[20]  
Musser JMB, 1998, J VET PHARMACOL THER, V21, P358, DOI 10.1046/j.1365-2885.1998.00148.x